Cargando…
Corrigendum to “Assessment of 105 Patients with Angiotensin Converting Enzyme-Inhibitor Induced Angioedema”
Autores principales: | Rasmussen, Eva Rye, von Buchwald, Christian, Wadelius, Mia, Prasad, Sumangali Chandra, Kamaleswaran, Shailajah, Ajgeiy, Kawa Khaled, Authried, Georg, Pallesen, Kristine Appel U., Bygum, Anette |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5852895/ https://www.ncbi.nlm.nih.gov/pubmed/29686707 http://dx.doi.org/10.1155/2018/9169414 |
Ejemplares similares
-
Assessment of 105 Patients with Angiotensin Converting Enzyme-Inhibitor Induced Angioedema
por: Rasmussen, Eva Rye, et al.
Publicado: (2017) -
Genetic susceptibility to angiotensin-converting enzyme-inhibitor induced angioedema: A systematic review and evaluation of methodological approaches
por: Ali, Haivin Aziz, et al.
Publicado: (2019) -
The Use of Plasma-Derived Complement C1-Esterase Inhibitor Concentrate (Berinert®) in the Treatment of Angiotensin Converting Enzyme-Inhibitor Related Angioedema
por: Hermanrud, Thorbjørn, et al.
Publicado: (2016) -
Correction: Genetic susceptibility to angiotensin-converting enzyme-inhibitor induced angioedema: A systematic review and evaluation of methodological approaches
por: Ali, Haivin Aziz, et al.
Publicado: (2019) -
Genome-wide association study of angioedema induced by angiotensin-converting enzyme inhibitor and angiotensin receptor blocker treatment
por: Rasmussen, Eva Rye, et al.
Publicado: (2020)